6681 — BrainAurora Medical Technology Cashflow Statement
0.000.00%
Last trade - 00:00- HK$4.94bn
- HK$5.09bn
- CNY220.05m
Annual cashflow statement for BrainAurora Medical Technology, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -698 | -502 | -359 | -199 | -316 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 648 | 398 | 227 | 64.3 | 134 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.2 | -8.8 | -25.7 | -38.9 | -22.2 |
| Change in Accounts Receivable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -49.2 | -101 | -137 | -146 | -178 |
| Capital Expenditures | -11.1 | -19.1 | -18.1 | -17.8 | -27.7 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -10.4 | -315 | 121 | 141 | -245 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -21.5 | -334 | 103 | 123 | -273 |
| Financing Cash Flow Items | 109 | 139 | 50.2 | -2.98 | -101 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 394 | 140 | 63.5 | 309 | 339 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 323 | -295 | 29.3 | 286 | -119 |